Ftse Mib
33.577,42
-0,39%
DAX
18.155,24
-0,04%
S&P 500
5.472,40
0,06%
NASDAQ
17.744,70
0,15%
Bitcoin
61.408,29
-0,65%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Heat Biologics Inc (HTBX) Heat Biologics Inc (HTBX) Notizie

HTBX

Heat Biologics (HTBX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:HTBX
DataOraFonteTitoloSimboloCompagnia
15/05/202322:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HTBXHeat Biologics Inc
15/05/202322:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HTBXHeat Biologics Inc
31/03/202322:15Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HTBXHeat Biologics Inc
30/12/202222:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:HTBXHeat Biologics Inc
09/12/202223:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HTBXHeat Biologics Inc
06/06/202222:29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:HTBXHeat Biologics Inc
18/03/202212:35TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Biolase (BIOL), Heat Biologics (HTBX)NASDAQ:HTBXHeat Biologics Inc
11/03/202212:33Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:HTBXHeat Biologics Inc
11/02/202223:17Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:HTBXHeat Biologics Inc
08/02/202223:04Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NASDAQ:HTBXHeat Biologics Inc
02/02/202222:05GlobeNewswire Inc.Heat Biologics Announces Planned Transfer to the NYSE AmericanNASDAQ:HTBXHeat Biologics Inc
31/01/202213:30GlobeNewswire Inc.Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human ServicesNASDAQ:HTBXHeat Biologics Inc
12/01/202214:00GlobeNewswire Inc.Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110NASDAQ:HTBXHeat Biologics Inc
22/12/202113:05TipRanksB.Riley Financial Thinks Heat Biologics’ Stock is Going to RecoverNASDAQ:HTBXHeat Biologics Inc
21/12/202113:30GlobeNewswire Inc.Heat Biologics Announces Planned Acquisition of Elusys TherapeuticsNASDAQ:HTBXHeat Biologics Inc
30/11/202113:30GlobeNewswire Inc.Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological ThreatsNASDAQ:HTBXHeat Biologics Inc
10/11/202122:05GlobeNewswire Inc.Heat Biologics Provides Third Quarter 2021 Business UpdateNASDAQ:HTBXHeat Biologics Inc
06/10/202113:30GlobeNewswire Inc.Heat Biologics Appoints Paul Tebbey as Senior Vice President of Product Development and Portfolio StrategyNASDAQ:HTBXHeat Biologics Inc
15/09/202113:30GlobeNewswire Inc.Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29thNASDAQ:HTBXHeat Biologics Inc
09/09/202114:30GlobeNewswire Inc.Heat Biologics to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceNASDAQ:HTBXHeat Biologics Inc
30/08/202113:30GlobeNewswire Inc.Heat Biologics to Provide Corporate UpdateNASDAQ:HTBXHeat Biologics Inc
26/08/202114:00GlobeNewswire Inc.Heat Biologics Unveils Skunkworx Bio, New Drug Discovery SubsidiaryNASDAQ:HTBXHeat Biologics Inc
23/08/202114:00GlobeNewswire Inc.Heat Biologics Announces Addition of Former US Senator Mark Pryor to Biothreat Advisory BoardNASDAQ:HTBXHeat Biologics Inc
19/08/202115:00GlobeNewswire Inc.Heat Biologics Announces New Additions to Biothreat Advisory BoardNASDAQ:HTBXHeat Biologics Inc
18/08/202114:00GlobeNewswire Inc.Heat Biologics Announces Formation of Biothreat Advisory BoardNASDAQ:HTBXHeat Biologics Inc
11/08/202122:05GlobeNewswire Inc.Heat Biologics Provides Second Quarter 2021 Business UpdateNASDAQ:HTBXHeat Biologics Inc
09/08/202113:30GlobeNewswire Inc.Heat Biologics Announces Groundbreaking for New San Antonio FacilityNASDAQ:HTBXHeat Biologics Inc
03/08/202122:43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HTBXHeat Biologics Inc
28/06/202113:30GlobeNewswire Inc.Heat Biologics Joins Russell Microcap® IndexNASDAQ:HTBXHeat Biologics Inc
23/06/202113:30GlobeNewswire Inc.Heat Biologics Announces Significant Expansion of R&D and Pre-Clinical Capabilities at Corporate HeadquartersNASDAQ:HTBXHeat Biologics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:HTBX

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
TIT
Telecom Italia
BIT
SRG
Snam
BIT
LDO
Leonardo
BIT
G
Generali
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network